The p.Arg282Trp mutation diagnosed in our patient involves a recognized “hot-spot” residue in p53’s DNA-binding domain, among the most common TP53 mutations in human cancers [9], and has been previously described associated with early onset of familial cancers [10]. Here, TP53 is linked to cancer.